ClinicalTrials.gg
CompletedNCT06971783Updated May 21, 2025

Effect of an Experimental Gel Based on Acmella Oleracea Extract Associated or Not With Fluoride on Dentin Hypersensitivity

An interventional study of CT- control group and NP- Potassium nitrate gel in Dentin Desensitizers, Non-carious Cervical Lesions and Dentin Hypersensitivity, sponsored by Universidade Federal do Para. Completed at 1 site in Brazil. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-05-21.

Sponsored by Universidade Federal do Para · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Aug 2024, registered May 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Dentin Sensitivity by Universidade Federal do Para — 2 open to participants now, 2 under way, 1 of them phase 3. Dentin Sensitivity · Universidade Federal do Para.

Enrollment
Largest of 19
100 · median 50
Started
2024
with 4 others
No phase
14 of 19
none open now
Registered
16th of 19
by date

Among the 19 studies in Dentin Sensitivity by Universidade Federal do Para, this one has the largest enrollment, is one of 5 that started in 2024, is one of 14 with no phase, and was the 16th registered.

Dentin Sensitivity

292 studies on the registry are indexed under Dentin Sensitivity; 49 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

2 of the 19 studies in Dentin Sensitivity by Universidade Federal do Para are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 20 Dentin Sensitivity studies recruiting now, 6 (30%) set no upper age limit and 13 (65%) stop at 75 or younger; 2 take children under 18; 12 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Dentin Sensitivity by Universidade Federal do Para, or all of them as a file.
02

Study summary

This randomized, single-blind, placebo-controlled clinical trial aims to evaluate the effect of an experimental gel based on Acmella oleracea (jambú) extract, associated or not with fluoride, in reducing dentin hypersensitivity (DH) in non-carious cervical lesions. The volunteers were randomized into 4 groups according to the treatments applied: CT (control), NP (potassium nitrate), AO (Acmella oleracea) and AF (Acmella oleracea associated with fluoride). Prophylaxis with pumice stone and water was performed on the previously selected teeth and, subsequently, the gels were applied to the cervical region with a microbrush, rubbed for 10 seconds, and remained on the tooth surface for 10 minutes. Three gel application sessions were performed, with 1-week interval between them. The DH evaluation was performed at four time points: baseline (before the first session), T1 (before the second session), T2 (before the third session) and T3, one week after the final application of the products.

Read the detailed description

Initially, all volunteers will undergo prophylaxis with pumice and water and will receive an oral hygiene kit containing a soft-bristled toothbrush, dental floss, and their assigned toothpaste, along with oral hygiene instructions. Relative isolation with cotton rolls will be performed in the region of the sensitive lesions, followed by the application of the gel corresponding to the participant's group (CT, NP, AO, AF). All gels will be applied in the same manner, using a microbrush applicator. After being rubbed for 20 seconds on each tooth, the gel will remain on the tooth surface for 10 minutes. At the end of this period, the gel will be removed using gauze and thoroughly rinsed. Three clinical sessions will be conducted, with one-week intervals between them.

03

Conditions studied

  • Dentin Desensitizers
  • Non-carious Cervical Lesions
  • Dentin Hypersensitivity

Browse trials for

Keywords

  • Acmella oleracea
  • Spilanthol
  • Dentin hypersensitivity
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of non-carious cervical lesions with sensitivity and up to 2 mm in depth
  • Miller Class I gingival recession
  • Lesions located on the buccal surface of the teeth
  • Score ≥ 4 on the Visual Analog Scale (VAS) after tactile and evaporative stimuli
  • Healthy periodontal condition
  • No other conditions that could explain dentin
  • Good general physical health
  • No eating disorders or high-acid diets
  • Occlusal stability

Exclusion criteria

Exclusion Criteria:

  • Presence of restorations in the hypersensitive areas
  • Presence of dental caries, pulpitis, or periodontal pockets
  • Enamel cracks
  • Systemic diseases
  • Continuous use of antibiotics, anti-inflammatory drugs, analgesics, or
  • Professional desensitizing treatment received within the three months prior to study recruitment
  • Pregnancy or breastfeeding Ongoing orthodontic treatment
  • Dental prostheses that may interfere with the assessment of
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Placebo comparator
    CT group: negative control group

    the group will receive the application of gel without active ingredient

    Other: CT- control group

  • Active comparator
    NP Group - Potassium nitrate associated with 2% Fluoride

    the group will receive the application of gel containing potassium nitrate

    Other: NP- Potassium nitrate gel

  • Experimental
    Group AO - Acmella Oleracea extract gel

    the group will receive the application of gel containing Acmella Oleracea Extract Gel

    Other: AO - Acmella Oleracea Extract Gel

  • Experimental
    AF Group - Acmella Oleracea extract gel associated with Fluoride.

    the group will receive the application of gel containing Acmella Oleracea Extract Gel associated with fluoride

    Other: AF - Gel of Acmella Oleracea extract associated with Fluoride.

Interventions

  • OtherCT- control group

    will receive the application of a placebo gel (without active ingredient), under the same conditions described for the experimental gel.

  • OtherNP- Potassium nitrate gel

    The gels will be applied to the sensitive lesions according to the experimental group and will be rubbed for 20 seconds using a microbrush, remaining on the lesions for 10 minutes.

  • OtherAO - Acmella Oleracea Extract Gel

    The Acmella oleracea gel will be applied to sensitive lesions and rubbed for 20 seconds with the aid of a microbrush, remaining on the lesions for 10 minutes.

  • OtherAF - Gel of Acmella Oleracea extract associated with Fluoride.

    The Acmella oleracea gel associated with fluoride will be applied to sensitive lesions and rubbed for 20 seconds with the aid of a microbrush, remaining on the lesions for 10 minutes.

06

What researchers measure

Primary outcomes

  1. sensitivity assessment

    Dentin hypersensitivity (DH) will be assessed at four time points: baseline (immediately before the first session), T1 (immediately before the second session), T2 (immediately before the third session), and T3 (one week after the final application of the products). DH will be evaluated using the Visual Analog Scale (VAS). This scale consists of a 10 cm horizontal line with scores of 0 and 10 at each end, where 0 indicates no sensitivity and 10 indicates severe dental sensitivity. Patients will be instructed to draw a vertical line along the horizontal scale to indicate the intensity of their dental sensitivity on the day of assessment.The distance from the zero end to the patient's mark will be measured using a millimeter ruler. These data will be recorded and tabulated for subsequent analysis.

    Time frame: 30 days

07

Study locations

1 site
  • Universidade Federal Do Para
    Belém, Pará, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Mar 2025, 7 months.

Of 113 non-industry interventional studies with no phase under Dentin Sensitivity, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 13. This study's 7 months is close to that.

Counting every sponsor, half of 147 studies reached it within 6 months; a quarter within 3 and three quarters within 10.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2025
First posted
May 14, 2025
StartActual
Aug 20, 2024
Primary completionActual
Mar 20, 2025
CompletionActual
Mar 20, 2025
Last update
May 21, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06971783
Lead sponsor
Universidade Federal do Para
Responsible party
Cecy Martins Silva (Professor of the Graduate Program in Dentistry at the Federal University of Pará, Universidade Federal do Para) — Principal investigator
First posted
May 14, 2025
Start date
Aug 20, 2024
Primary completion
Mar 20, 2025
Completion
Mar 20, 2025
Last update
May 21, 2025

Study contacts

Cecy M Silva
principal investigator · universidade federal do pará

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion